Immunocore Holdings (IMCR) Research & Development (2021 - 2026)
Immunocore Holdings (IMCR) posted Research & Development of $73.95 million for Q2 2026, up 7.2% from $69.01 million a year earlier and up 21.0% from the prior quarter.
Powered by 
Analysis
Immunocore Holdings (IMCR) Research & Development (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Immunocore Holdings was $284.45 million, up 19.0% year-over-year; for FY2025, it came in at $274.87 million, up 23.7% from FY2024.
- Annual Research & Development has increased for five consecutive years, with a five-year compound annual growth rate of 22.7% (FY2020 to FY2025).
- In prior years, Immunocore Holdings' Research & Development was $222.15 million in FY2024 (+35.8%), $163.55 million in FY2023 (+60.5%), $101.92 million in FY2022 (+1.7%) and $100.25 million in FY2021 (+1.5%).
- Quarterly Research & Development has run from a low of $23.16 million in Q3 2021 to a high of $78.82 million in Q4 2025 over five years.
- On a year-over-year basis, Research & Development has increased in each of the last five quarters, with growth averaging 21.0% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q3 2023, with growth of 57.5%; the weakest was Q1 2025, with a decline of 1.7%.
- According to Business Quant data, Research & Development for the three prior quarters was $61.11 million (Q1 2026), $78.82 million (Q4 2025) and $70.57 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Immunocore Holdings | 1.58 Bn | -1.90 Bn | 114.84 Mn | 73.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 73.95 Mn |
| Mar 31, 2026 | 61.11 Mn |
| Dec 31, 2025 | 78.82 Mn |
| Sep 30, 2025 | 70.57 Mn |
| Jun 30, 2025 | 69.01 Mn |
| Mar 31, 2025 | 56.47 Mn |
| Dec 31, 2024 | 60.85 Mn |
| Sep 30, 2024 | 52.77 Mn |
| Jun 30, 2024 | 51.07 Mn |
| Mar 31, 2024 | 57.46 Mn |
| Dec 31, 2023 | 45.57 Mn |
| Sep 30, 2023 | 43.25 Mn |
| Jun 30, 2023 | 38.16 Mn |
| Mar 31, 2023 | 36.57 Mn |
| Dec 31, 2022 | 31.83 Mn |
| Sep 30, 2022 | 27.46 Mn |
| Jun 30, 2022 | 25.38 Mn |
| Dec 31, 2021 | 27.06 Mn |
| Sep 30, 2021 | 23.16 Mn |
API Access
Immunocore Holdings Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=IMCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "IMCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=IMCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();